Product Program year 2023 Source: CMS Open Payments

OLYMPUS EndoTherapy Inflation Device for Endoscopic Balloon Dilation

Device EndoTherapy

PDI 00856877002537

Open in the dashboard

General payments

$125,015

36 payments

Research payments

$0

0 payments

Through program year 2023, $125,015 in general payments and $0 in research payments were reported against OLYMPUS EndoTherapy Inflation Device for Endoscopic Balloon Dilation (EndoTherapy).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2023 General $124,801 22
2022 General $214 14

Breakdown

Who paid General payments · program years 2022–2023
  1. Olympus Corporation of the Americas $101,126 1 payment
  2. Olympus America Inc. $23,889 35 payments
Top recipients General payments · program year 2023
  1. Uci Medical Center Teaching hospital · CA $101,126 81% · 1 payment
  2. Ut Md Anderson Cancer Center Teaching hospital · TX $23,362 19% · 1 payment
  3. Memorial Hospital At Gulfport Teaching hospital · MS $41 <1% · 1 payment
  4. Gursimran Kochhar Gastroenterology · Pittsburgh, PA $28 <1% · 1 payment
  5. Fred Ruymann Gastroenterology · Cambridge, MA $27 <1% · 2 payments

The top 5 of 20 recipients; each share is of general payments naming this product in 2023.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2023
  1. Gastroenterology Internal Medicine $160 64% · 10 practitioners
  2. Colon & Rectal Surgery $31 12% · 2 practitioners
  3. Surgery $15 6% · 1 practitioner
  4. Internal Medicine $15 6% · 1 practitioner
  5. Anesthesiology $14 6% · 1 practitioner

The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2023
  1. California $101,250 81% · 9 recipients
  2. Texas $23,362 19% · 1 recipient
  3. Mississippi $56 <1% · 2 recipients
  4. Massachusetts $47 <1% · 2 recipients
  5. Louisiana $35 <1% · 2 recipients

The top 5 of 8 states; each share is of general payments naming this product in 2023 where a state was reported.

The top 25 states, free in the app

36 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record